- Targeting Histamine Receptors in Irritable Bowel Syndrome: A Critical Appraisal
-
Fabisiak A, WÅ‚odarczyk J, Fabisiak N, Storr M, Fichna J
- KMID: 2387824
- J Neurogastroenterol Motil.
- 2017 Jul;23(3):341-348.
- doi: 10.5056/jnm16203
Irritable bowel syndrome is a group of functional gastrointestinal disorders with not yet fully clarified etiology. Recent evidence suggesting that mast cells may play a central role in the pathogenesis... -
- CITED
-
- Close
- SHARE
-
- Close
- Future Treatment of Constipation-associated Disorders: Role of Relamorelin and Other Ghrelin Receptor Agonists
-
Mosińska , Zatorski H, Storr M, Fichna J
- KMID: 2433518
- J Neurogastroenterol Motil.
- 2017 Apr;23(2):171-179.
- doi: 10.5056/jnm16183
There is an unmet need for effective pharmacological therapies for constipation, a symptom that significantly deteriorates patients' quality of life and impacts health care. Ghrelin is an endogenous ligand for... -
- CITED
-
- Close
- SHARE
-
- Close
- Lichen Planus Is an Uncommon Cause of Nonspecific Proximal Esophageal Inflammation
-
Linton MS, Zhao L, Gui X, Storr M, Andrews CN
- KMID: 1806636
- Gut Liver.
- 2013 Jul;7(4):401-405.
BACKGROUND/AIMS: Esophageal lichen planus (LP) has been described as a cause of nonspecific esophagitis that may cause dysphagia, but its incidence is unknown. We aimed to estimate the incidence of... -
- CITED
-
- Close
- SHARE
-
- Close
- Probiotic Therapy of the Irritable Bowel Syndrome: Why Is the Evidence Still Poor and What Can Be Done About It?
-
Mazurak N, Broelz E, Storr M, Enck P
- KMID: 2381295
- J Neurogastroenterol Motil.
- 2015 Oct;21(4):471-485.
- doi: 10.5056/jnm15071
BACKGROUND/AIMS: Despite numerous randomized clinical trials and meta-analyses, there is no increased evidence for the efficacy of probiotics in the treatment of irritable bowel syndrome (IBS). We review this evidence,... -
- CITED
-
- Close
- SHARE
-
- Close
